John G Ullman & Associates Inc Buys Merck Inc, Itron Inc, Ultra Clean Holdings Inc, Sells Johnson & Johnson, GlaxoSmithKline PLC, Albemarle Corp

• New Purchases: UCTT, OCDX, BE, STT, EBMT, ACVA, EA, CHWY, LECO, HPE, APH, AVLNF,
• Added Positions: MRK, ITRI, IIVI, VWO, EEMV, MCFE, GLW, FLS, VOO, BAX, TPC, TMP, SLB, VZ, KBH, AQN, WEC, AAPL,
• Reduced Positions: JNJ, GSK, XRX, AGX, EMR, ELAN, WTS, IBM, PFE, BCE, INTC, T, ZNGA, XOM, AMSWA, AQUA, CSCO, MSFT, EWS, ESBK, TSM, CACI, ACM, TEL, NVDA, NXST, AMT, PHG, SYNA, TMO, CCK, VMW WI, AVGO, HZNP, A, GOOG, LITE, VNM, LH, GE, GVA, EEFT, HON, LLY, ETN, VIAV, ASTE, IBB, OGN, AOS, VAW, IR, CMCSA, CIEN, MTSI, FETM, XLU, FELE, CAMP, HAL, IPGP, ASRV, HOLX, ITW, TT, SO, SWKS, SHW, BP, ORCL, JCI,
• Sold Out: ALB, ALC, CYD, USCR, GXC, DGX, OU5A,

For the details of JOHN G ULLMAN & ASSOCIATES INC's stock buys and sells, go to https://www.gurufocus.com/guru/john+g+ullman+%26+associates+inc/current-portfolio/portfolio

1. Emerson Electric Co (EMR) - 385,767 shares, 4.94% of the total portfolio. Shares reduced by 1.91%
2. Pfizer Inc (PFE) - 643,450 shares, 3.76% of the total portfolio. Shares reduced by 1.55%
3. OGE Energy Corp (OGE) - 783,244 shares, 3.51% of the total portfolio. Shares reduced by 0.24%
4. Verizon Communications Inc (VZ) - 431,390 shares, 3.17% of the total portfolio. Shares added by 1.86%
5. Corning Inc (GLW) - 635,820 shares, 3.16% of the total portfolio. Shares added by 4.20%

John G Ullman & Associates Inc initiated holding in Ultra Clean Holdings Inc. The purchase prices were between $39.72 and $54.13, with an estimated average price of $47.21. The stock is now traded at around $53.450000. The impact to a portfolio due to this purchase was 0.4%. The holding were 68,404 shares as of 2021-09-30.

John G Ullman & Associates Inc initiated holding in Ortho Clinical Diagnostics Holdings PLC. The purchase prices were between $17.75 and $22.47, with an estimated average price of $20.16. The stock is now traded at around $19.175000. The impact to a portfolio due to this purchase was 0.31%. The holding were 122,519 shares as of 2021-09-30.

John G Ullman & Associates Inc initiated holding in Bloom Energy Corp. The purchase prices were between $18.54 and $26.62, with an estimated average price of $21.25. The stock is now traded at around $32.275000. The impact to a portfolio due to this purchase was 0.25%. The holding were 96,700 shares as of 2021-09-30.

John G Ullman & Associates Inc initiated holding in State Street Corporation. The purchase prices were between $79.59 and $94.28, with an estimated average price of $87.03. The stock is now traded at around $99.315000. The impact to a portfolio due to this purchase was 0.22%. The holding were 19,000 shares as of 2021-09-30.

John G Ullman & Associates Inc initiated holding in ACV Auctions Inc. The purchase prices were between $17.89 and $25.18, with an estimated average price of $21.27. The stock is now traded at around $19.365000. The impact to a portfolio due to this purchase was 0.17%. The holding were 69,784 shares as of 2021-09-30.

John G Ullman & Associates Inc initiated holding in Eagle Bancorp Montana Inc. The purchase prices were between $21.62 and $23.13, with an estimated average price of $22.25. The stock is now traded at around $22.600000. The impact to a portfolio due to this purchase was 0.17%. The holding were 55,135 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in Merck & Co Inc by 60.56%. The purchase prices were between $71.68 and $78.83, with an estimated average price of $76.11. The stock is now traded at around $89.780000. The impact to a portfolio due to this purchase was 0.49%. The holding were 127,523 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in Itron Inc by 615.17%. The purchase prices were between $71.84 and $100.87, with an estimated average price of $85.82. The stock is now traded at around $80.270000. The impact to a portfolio due to this purchase was 0.46%. The holding were 51,850 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in II-VI Inc by 215.55%. The purchase prices were between $59.29 and $74.08, with an estimated average price of $65.35. The stock is now traded at around $63.480000. The impact to a portfolio due to this purchase was 0.29%. The holding were 51,750 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in Vanguard FTSE Emerging Markets ETF by 178.69%. The purchase prices were between $48.9 and $53.52, with an estimated average price of $51.26. The stock is now traded at around $50.600000. The impact to a portfolio due to this purchase was 0.24%. The holding were 54,119 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in BTC iShares MSCI Emerging Markets Min Vol Factor E by 163.98%. The purchase prices were between $61.06 and $64.43, with an estimated average price of $62.91. The stock is now traded at around $63.115000. The impact to a portfolio due to this purchase was 0.22%. The holding were 42,500 shares as of 2021-09-30.

John G Ullman & Associates Inc added to a holding in McAfee Corp by 120.05%. The purchase prices were between $20.9 and $31.26, with an estimated average price of $25.91. The stock is now traded at around $21.325000. The impact to a portfolio due to this purchase was 0.16%. The holding were 95,500 shares as of 2021-09-30.

John G Ullman & Associates Inc sold out a holding in Albemarle Corp. The sale prices were between $167.91 and $244.03, with an estimated average price of $213.35.

John G Ullman & Associates Inc sold out a holding in Alcon Inc. The sale prices were between $68.18 and $87.25, with an estimated average price of $76.98.

John G Ullman & Associates Inc sold out a holding in China Yuchai International Ltd. The sale prices were between $12.63 and $16.31, with an estimated average price of $14.55.

John G Ullman & Associates Inc sold out a holding in . The sale prices were between $71.96 and $74.41, with an estimated average price of $73.36.

John G Ullman & Associates Inc sold out a holding in SPDR S&P China ETF. The sale prices were between $108.07 and $131.38, with an estimated average price of $117.11.

John G Ullman & Associates Inc sold out a holding in Quest Diagnostics Inc. The sale prices were between $132.95 and $158, with an estimated average price of $146.26.